Apyx Medical Inc (APYX) Reports the reporting period Financial Results
Apyx Medical Inc (APYX) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: $19
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: Not disclosed
expected increase in aesthetic surgical procedures in the U.S. This positive industry momentum is being fueled, in part, by the adoption of GLP-1 therapies resulting in significant patient weight loss and loose and lax skin.” This press release includes Apyx Medical Corporation’s preliminary revenue results for the quarter and full year ended December 31, 2025
📋 Apyx Medical Inc (APYX) - Financial Results
Filing Date: 2026-01-12
Accepted: 2026-01-12 08:02:36
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: